Paper Details

  1. Home
  2. Paper Details

Postoperative adjuvant therapy for stage II non-small-cell lung cancer.

Author: BaekH J, ChoK J, ChoeD H, KimM S, LeeC T, ParkJ H, ShimY M, ZoJ I

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Stage II non-small-cell lung cancer is an early form of lung cancer. While surgery, including removal of lymph nodes in the chest, is the standard treatment, survival rates are not good. The most common causes of death are the cancer returning in the same area or spreading to other parts of the body. There is no clear consensus on the best additional treatments to improve survival after surgery.
Paper Details　
Original Abstract of the Article :
Stage II non-small-cell lung cancer is regarded as one of the early lung cancers. Although resection, including the mediastinal lymph nodes, is currently regarded as the standard treatment, the survival rate of this disease is not encouraging. It is well known that the most common causes of death ar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0003-4975(99)00715-8

データ提供：米国国立医学図書館（NLM）

Postoperative Adjuvant Therapy for Stage II Non-Small-Cell Lung Cancer

This research explores the challenges of treating non-small-cell lung cancer, a disease that can be like a treacherous desert, full of hidden dangers and unpredictable pathways. The study focuses on Stage II non-small-cell lung cancer, which is considered an early stage but can still be quite difficult to treat. The authors reviewed the current standard treatment, which includes surgical resection, and investigated the effectiveness of adjuvant therapy in improving survival outcomes. They found that while resection is a crucial step, the survival rate is still not encouraging. The research is like examining the landscape of a desert, trying to identify the best route to navigate the challenges of this disease.

Navigating the Desert of Lung Cancer

The study reveals a sobering reality about Stage II non-small-cell lung cancer. Despite advancements in treatment, the survival rate remains a concern. The researchers are looking for ways to improve outcomes by exploring the use of adjuvant therapies after surgery. This is like searching for a hidden oasis that could provide a source of hope and healing for patients.

Finding the Right Path Forward

The study highlights the need for further research to determine the most effective adjuvant therapies for Stage II non-small-cell lung cancer. It's like searching for the best path through the desert, seeking a way to increase survival rates and improve the lives of patients. This research is a crucial step in finding a more effective and less dangerous path through the desert of lung cancer.

Dr.Camel's Conclusion

This research is a reminder that the journey through lung cancer can be long and difficult. However, by continuing to research and explore new treatment options, we can hopefully find a more effective and less treacherous path through this disease. It's a journey that requires perseverance and a belief in the power of hope.

Date :
  1. Date Completed 1999-12-14
  2. Date Revised 2019-06-28
Further Info :

Pubmed ID

10585065

DOI: Digital Object Identifier

10.1016/s0003-4975(99)00715-8

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.